HALEH FITZGERALD: Open Payments
NPI 1730551920 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 4 payments from 2 companies in 2025. Trend: 2023 $123 · 2024 $426 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $50 |
| Celgene Corporation | 2 | $34 |
Products named: REBLOZYL, BLENREP, OJJAARA.
Industry payments across NY — which companies pay providers there.
